Novo Nordisk recently announced a policy requiring covered entities to submit 340B claims data for utilization at in-house pharmacies.

Novo Nordisk Latest Drugmaker to Announce 340B Claims Data Requirements for In-House Pharmacies

March 3, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

Danish pharmaceutical giant Novo Nordisk has announced plans to require all covered entities to submit claims data for in-house pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!